| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.31 | 0.06 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.083 | 0.07 |